The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities
Abstract
Fucoidan, a sulfated polysaccharide extracted from brown seaweed, has anticoagulant and antithrombotic activities. Unlike heparin, it shows an inhibitory action on the progression and metastasis of malignant tumors, although the precise mechanisms have not been elucidated. We have demonstrated previously that fucoidan can inhibit tube formation following migration of human umbilical vein endothelial cells (HUVEC) and that its chemical oversulfation enhances the inhibitory potency. In this study, we tested the hypothesis that fucoidan may suppress tumor growth by inhibiting tumor-induced angiogenesis. Both natural and oversulfated fucoidans (NF and OSF) significantly suppressed the mitogenic and chemotactic actions of vascular endothelial growth factor 165 (VEGF(165)) on HUVEC by preventing the binding of VEGF(165) to its cell surface receptor. The suppressive effect of OSF was more potent than that of NF, suggesting an important role for the numbers of sulfate groups in the fucoidan molecule. Consistent with its inhibitory actions on VEGF(165), OSF clearly suppressed the neovascularization induced by Sarcoma 180 cells that had been implanted in mice. The inhibitory action of fucoidan was also observed in the growth of Lewis lung carcinoma and B16 melanoma in mice. These results indicate that the antitumor action of fucoidan is due, at least in part, to its anti-angiogenic potency and that increasing the number of sulfate groups in the fucoidan molecule contributes to the effe…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The results showed that both native and oversulfated FCSPs were able to suppress neovascularization in mice implanted Sarcoma-180 cells; and that both FCSPs types inhibited tumor growth through the prevention of tumor-induced angiogenesis, but the data indicated that sulfation tended to give more potent effects [88].”
In the citing paper
“The interaction of oversulfated FCSPs with VEGF165 occurred with high affinity and resulted in the formation of highly stable complexes, thereby interfering with the binding of VEGF165 to vascular endothelial growth factor receptor-2 (VEGFR-2).”
In the citing paper
“When the importance of the spatial orientation of the negative charges on the FCSPs was investigated in more depth it was confirmed that this feature plays a major role in determining the binding potency of FCSPs to vascular endothelial growth factor 165 (VEGF165) [88].”
In the citing paper
“These data showed that antiangiogenic and antitumor activity of fucoidans can be potentiated by increasing the sulfate groups in the molecule [51].”
From Anticancer and Cancer Preventive Properties of Marine Polysaccharides: Some Results and Prospects (2013) · cites this paper as [51]
In the citing paper
“Fucoidans may suppress tumor growth by inhibiting tumor-induced angiogenesis.”
From Anticancer and Cancer Preventive Properties of Marine Polysaccharides: Some Results and Prospects (2013) · cites this paper as [51]
Citations
Cites
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,627
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V, & Kehrl, J. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4167 · Cited by 2,866
Folkman, J., & Shing, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49853-0 · Cited by 2,654
Molecular and Biological Properties of the Vascular Endothelial Growth Factor Family of Proteins
FERRARA, N., HOUCK, K., JAKEMAN, L., & LEUNG, D. W. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-18 · Cited by 1,655
Takahashi, Y., Kitadai, Y., Bucana, C. D., Cleary, K. R., & Ellis, L. M. (1995) · PubMed · Cited by 1,265
Klagsbrun, M., & D'Amore, P. A. (1991) · Annual Review of Physiology · doi:10.1146/annurev.ph.53.030191.001245 · Cited by 957
Basic fibroblast growth factor induces angiogenesis in vitro.
Montesano, R., Vassalli, J. D., Baird, A., Guillemin, R., & Orci, L. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.19.7297 · Cited by 844
Ishikawa, F., Miyazono, K., Hellman, U., Drexler, H., Wernstedt, C., Hagiwara, K., Usuki, K., Takaku, F., Risau, W., & Heldin, C.-H. (1989) · Nature · doi:10.1038/338557a0 · Cited by 711
Cited by
Astruc, D., Boisselier, E., & Ornelas, C. (2010) · Chemical Reviews · doi:10.1021/cr900327d · Cited by 1,844
Cumashi, A., Ushakova, N. A., Preobrazhenskaya, M. E., D'Incecco, A., Piccoli, A., Totani, L., Tinari, N., Morozevich, G. E., Berman, A. E., Bilan, M. I., et al. (2007) · Glycobiology · doi:10.1093/glycob/cwm014 · Cited by 1,026
Ale, M. T., Mikkelsen, J. D., & Meyer, A. S. (2011) · Marine Drugs · doi:10.3390/md9102106 · Cited by 779
Biological activities of sulfated polysaccharides from tropical seaweeds
Costa, L. S., Fidelis, G. P., Cordeiro, S. L., Oliveira, R. M., Sabry, D. A., Câmara, R. B. G., Nobre, L. T. D. B., Costa, M. S. S. P., Almeida-Lima, J., Farias, E. H. C., et al. (2010) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2009.03.005 · Cited by 659
Antioxidant activities of enzymatic extracts from brown seaweeds
HEO, S., PARK, E., LEE, K., & JEON, Y. (2005) · Bioresource Technology · doi:10.1016/j.biortech.2004.07.013 · Cited by 650
Metadata
- Authors
- Koyanagi, S., Tanigawa, N., Nakagawa, H., Soeda, S., & Shimeno, H.
- Affiliations
- Fukuoka University (JP)
- Corresponding author
- Shimeno, Hiroshi
- ORCID
- Koyanagi, Satoru
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2003-01
- Volume
- 65
- Issue
- 2
- Pages
- 173-179
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W2061760856
- Cited by
- 479
- References
- 27
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 10 · 2023: 18 · 2022: 23 · 2021: 24 · 2020: 33 · 2019: 31 · 2018: 24 · 2017: 21 · 2016: 16 · 2015: 29 · 2014: 28 · 2013: 34 · 2012: 26
- FWCI
- 16.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Biochemical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Pharmacology (medical) › Fungal Biology and Applications
- Keywords
- fucoidan, sulfated polysaccharides, antiangiogenic activity, anticancer activity, VEGF165, VEGF receptor binding, endothelial tube formation, neovascularization, sarcoma 180, Lewis lung carcinoma, B16 melanoma, brown seaweed polysaccharides, sulfate groups
- MeSH terms
- Animals, Antineoplastic Agents, Cell Division, Cell Movement, Cells, Cultured, Disease Models, Animal, Endothelium, Vascular, Humans, Lymphokines, Melanoma, Experimental, Neoplasm Transplantation, Neovascularization, Pathologic, Phosphorylation, Polysaccharides, Sulfur, Endothelial Growth Factors, Angiogenesis Inhibitors, Intercellular Signaling Peptides and Proteins, Vascular Endothelial Growth Factor Receptor-2, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. https://app.cochat.ai/papers/10.1016/s0006-2952(02)01478-8
- The paper
- Koyanagi, S., Tanigawa, N., Nakagawa, H., Soeda, S., & Shimeno, H. (2003). Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. Biochemical Pharmacology. https://doi.org/10.1016/s0006-2952(02)01478-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.